Organisation paid for research Program year 2023 Source: CMS Open Payments

Massresearch, LLC

Neither a doctor nor a teaching hospital

Research payments

$220,003

692 payments

Through program year 2023, Massresearch, LLC is reported as receiving $220,003 in research payments, across 692 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$5,721	7
2022	Research	$18,363	21
2021	Research	$154,565	658
2020	Research	$41,355	6

Breakdown

Who paid Research payments · program years 2020–2023

Novo Nordisk AS $167,103 685 payments
Sanofi US Services Inc. $52,900 7 payments

Studies the money was for Research payments · program years 2020–2023

Nn1436-4478 $117,331 601 payments
Nn9924-4635 $49,772 84 payments
Randomized, Open Label, Parallel-group Study Comparing the Pharmacokinetics and Immunogenicity of Alternating Use of SAR341402 and NovoLog Versus Continuous Use of NovoLog in Participants With Type 1 Diabetes Mellitus Also Using Insulin Glargine $36,948 6 payments
Six-month, Randomized, Open-label, Parallel-group Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Also Using Insulin Glargine, With a 6-month Safety Extension Period $15,953 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.